Cellectis CLLS
NASDAQ CLLS
$1.40 -0.11 (-7.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cellectis (CLLS) Non Operating Income (2021 - 2022)

Updated

Cellectis (CLLS) reported Non Operating Income of $483,000 for Q4 2022, compared with $8,000 a year earlier.

Analysis

Cellectis (CLLS) Non Operating Income (2021 - 2022) Analysis & Trends

For FY2022, Cellectis posted Non Operating Income of $5.57 million.

  • By year, Non Operating Income came in at $19,000 in FY2021.
  • Five-year quarterly Non Operating Income spans a low of -$1,000 in Q1 2021 and a high of $487,000 in Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cellectis 151.51 Mn -601.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 483,000.00
Mar 31, 2022 487,000.00
Dec 31, 2021 8,000.00
Mar 31, 2021 -1,000.00
API Access

Cellectis Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CLLS&period=max&api_key=YOUR_API_KEY